The value of innovation in oncology – new recommendations from the European Cancer Patient Coalition
Lung cancer care: the technology is there, but what else is needed?
Lung cancer screening in the UK: yes or no?
Biosimilars are alternatives for original antibodies
Symptom control in advanced cancer - key issues and what we can do about it